PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 9 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous extracts of Speranskia tuberculata were identified as one of the most potent anti-mitotics in a high-throughput screen [PMID:24105850]
Evidence summary
PubMed sources
- 1.PMID: 10869201 (2000) — Polyoxygenated bipyridine, pyrrolylpyridine, and bipyrrole alkaloids from Speranskia tuberculata. · Journal of natural products
- 2.PMID: 33613598 (2021) — Insights Into the Significance of the Chinense Loess Plateau for Preserving Biodiversity From the Phylogeography of Speranskia tuberculata (Euphorbiaceae). · Frontiers in plant science
- 3.PMID: 27785384 (2016) — Development and characterization of novel EST-SSR markers for Speranskia tuberculata (Euphorbiaceae). · Applications in plant sciences
- 4.PMID: 40376160 (2025) — Intergeneric and interspecific relationships in tribe Ricineae revealed by phylogenomics of the plastome and transcriptome. · Frontiers in plant science
- 5.PMID: 42172619